Discover the potential of newborn Stem Cells

Stem Cell Banking is Once in a Lifetime Opportunity !
Know more about Cord Blood Banking with StemCyte India.


Welcome to StemCyte
A Global Regenerative Therapeutics Company


StemCyte India is a joint venture between StemCyte Inc. (USA), Apollo Hospitals Enterprises Ltd. and Cadila Pharmaceuticals Ltd. StemCyte India’s headquarter and processing facility is strategically located in Gujarat (The hub of Thalassemia and Sickle Cell Anemia).

Globally, StemCyte Inc., USA; StemCyte Taiwan and StemCyte India work on a “Hybrid+” model. Each establishment has a core competency in Public Cord Blood Banking, Private Cord Blood Banking, Therapeutic Applications and are also actively involved in Clinical Trials.

Our Mission : “StemCyte is dedicated to helping the world’s physicians save more lives by providing high quality, safe and effective stem cell transplantaion and therapy to all patients in need.”

Why Cord Blood Banking ?

Cord Blood are worth preserving. Your baby’s Cord Blood is a rich source of stem cells, the building blocks of our bodies, which can act as a “self-repair” kit.

It’s a once-in-a-lifetime opportunity to help protect your family’s long-term health.

Cord blood stem cells are genetically unique and are a 100% match for the same child. These stem cells may also be a match for siblings and other family members.

Cord blood stem cells hold the power to cure over 80 diseases. It is used in transplantation for treating various life threatening diseases. The odds that you will use the cord blood continue to increase as new therapies are being successfully proven.

Research is already being conducted using cord blood stem cells to treat spinal cord injury, Heart Diseases, Diabetes, Alzheimer’s, Parkinson’s, Cerebral palsy and many more common diseases.

If your family has a history of malignancies, blood disorders or immune deficiency diseases, then the likelihood that your baby or his/her siblings could need a stem cell transplant over their life time, increases.

StemCyte Differentiator

  • StemCyte Inc. USA was established in 1997. Brings greater than 20 years experience in cord blood banking.
  • Global footprint with operations in USA, Taiwan and India.
  • StemCyte India is a joint venture of StemCyte Inc.(USA), Apollo Hospitals and Cadila Pharmaceuticals.
  • Only company in India with FACT ( Foundation for the Accreditation of Cellular Therapy ).
  • USFDA approved collection bag, freezing bag, canisters, etc. are truly imported.
  • Our endeavor is to ensure that we meet the highest quality accredited standards by following 400 SOPs diligently.
  • 24/7 customer support at all stages – collection, testing, storage, retrieval and transplantation.
  • Public Bank – The UCB (Umbilical Cord Blood) is donated to StemCyte for processing & storage for further use by unrelated patients.
  • Private Bank – UCB is collected, processed & stored exclusively for the future medical needs of the child or the family.
  • Advanced Therapeutics – Treatment of patients in need.
  • Clinical Trials – Use of cord blood stem cells in indications like spinal cord injuries, stroke, etc.
  • One of the most important aspects in cord blood preservation is the recovery of stem cells.
  • StemCyte’s patented Plasma Depletion(PD) Technology yields up to 99.96% cell recovery.
  • Patient transplanted with plasma depleted cord blood receive.
    • Higher Cell Dose.
    • Lower Transplant Related Mortality.
    • Superior Engraftment.
    • Higher Rate of Survival.

Preserve your baby’s stem cells and secure your family’s future

Protection for your family…………for life………..

Call now on +91 99099 29988
Book a FREE Presentation

Contact Us

Apollo Hospital Campus, Plot No.1A, Bhat GIDC Estate, Dist. Gandhinagar 382 428, Gujarat, India.

PHONE : +91-79–6170 1001
FAX : +91-79–6170 1110
Call Now : +91 99099 29988